Literature DB >> 19212710

Concomitant renal cell carcinoma and lymphoid malignancies: a case series of five patients and review of the literature.

Songul Serefhanoglu1, Yahya Buyukasik, Hakan Goker, Safak Cavus Akin, Serkan Akin, Nilgun Sayinalp, Ibrahim Celalettin Haznedaroglu, Osman Ilhami Ozcebe.   

Abstract

Appearance of non-Hodgkin's lymphomas (NHL) and renal cell carcinoma (RCC) in same person has been reported in the literature. There is a higher-than-expected incidence of co-occurrence of these neoplastic disorders. The cause for this association remains speculative. Two epidemiological studies have shown that the observed-to-expected ratio for occurrence of RCC in NHL patients were 1.86 to 2.67. We herein describe five patients with both RCC and lymphoid malignancies, and reviewed possible explanations for the association. In three of the five patients, RCC was diagnosed during lymphoproliferative disease work-up, and remaining two cases had been diagnosed with chronic lymphocytic leukemia 1 and 5 years prior to RCC. All RCC cases were detected during staging of the primary tumor, usually by CT scan and/or ultrasound. Our data are in correlation with the literature that there is an increased association of RCC and NHL more often among male patients, and that the lymphoproliferative disease often presents with extranodal involvement. The specialists should be alerted for this possibility when evaluating patients at diagnosis or during follow-up.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19212710     DOI: 10.1007/s12032-009-9170-7

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  21 in total

1.  Synchronous ipsilateral renal adenocarcinoma, transitional cell carcinoma of the renal pelvis and metastatic renal lymphoma.

Authors:  J E Bernie; L Albers; S Baird; C L Parsons
Journal:  J Urol       Date:  2000-09       Impact factor: 7.450

2.  Interleukin-6 produced by renal-cell carcinoma cells and progression of multiple myeloma.

Authors:  A Sakai; M Kawano; A Kuramoto
Journal:  N Engl J Med       Date:  1991-06-27       Impact factor: 91.245

3.  An association between renal cell carcinoma and lymphoid malignancies: a case series of eight patients.

Authors:  I Barişta
Journal:  Cancer       Date:  1997-09-01       Impact factor: 6.860

4.  Primary cutaneous CD30 (Ki-1)-positive anaplastic large cell lymphoma associated with renal cell carcinoma.

Authors:  S A Shah; A D Ormerod; A Husain; P Kohle; D Culligan
Journal:  Br J Dermatol       Date:  1999-05       Impact factor: 9.302

Review 5.  Coincident renal cell carcinoma and nonHodgkin's lymphoma: the M. D. Anderson experience and review of the literature.

Authors:  C M Anderson; L Pusztai; J L Palmer; F Cabanillas; J A Ellerhorst
Journal:  J Urol       Date:  1998-03       Impact factor: 7.450

6.  Second primary malignancies associated with renal cell carcinoma: influence of histologic type.

Authors:  F Rabbani; V E Reuter; J Katz; P Russo
Journal:  Urology       Date:  2000-09-01       Impact factor: 2.649

7.  [Asynchronous occurrence of three neoplastic diseases: chronic B-cell lymphatic leukemia, renal carcinoma and prostatic adenocarcinoma].

Authors:  P Prosvic; P Dulícek; K Odrázka; J Navrátilová; P Morávek; P Macek; Z Veselský
Journal:  Rozhl Chir       Date:  2003-11

8.  Chromosome 17p deletions and p53 mutations in renal cell carcinoma.

Authors:  R E Reiter; P Anglard; S Liu; J R Gnarra; W M Linehan
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

9.  Renal parenchymal tumors and lymphoma in the same patient: case series and review of the literature.

Authors:  Anuradha Kunthur; Peter H Wiernik; Janice P Dutcher
Journal:  Am J Hematol       Date:  2006-04       Impact factor: 10.047

10.  Coexistence of renal cell carcinoma and malignant lymphoma. A causal relationship or coincidental occurrence?

Authors:  T Tihan; D A Filippa
Journal:  Cancer       Date:  1996-06-01       Impact factor: 6.860

View more
  3 in total

1.  Case Report: New Onset Lymphadenopathy After Immune Checkpoint Inhibitor Therapy Presents a Clinicopathological and Radiological Challenge.

Authors:  Matthew Scarlotta; Robin Avery; Ezra Baraban; Zahra Maleki; Yasser Ged
Journal:  Front Oncol       Date:  2022-05-20       Impact factor: 5.738

2.  Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families.

Authors:  Janice P Dutcher; Peter H Wiernik; Leticia Varella; Rangaswamy Chintapatla
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

3.  Chronic lymphocytic lymphoma and concomitant renal cell carcinoma (Clear Cell Type): Review of the literature.

Authors:  Burak Uz; Ilhan Dolasik; Ozlem Ucer; Adile Ferda Dagli; Sercan Simsek
Journal:  Leuk Res Rep       Date:  2016-06-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.